Amyotrophic lateral sclerosis/motor neuron disease deaths in the United States, 1999-2009

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 14, Issue 5-6, 2013, Pages 346-352

  Mehal, Jason M ^a   Holman, Robert C ^a   Schonberger, Lawrence B ^a   Sejvar, James J ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Amyotrophic lateral sclerosis; Mortality; Motor neuron disease

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOTOR NEURON DISEASE; PRIORITY JOURNAL; SEX RATIO; TREND STUDY; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; SEX DISTRIBUTION; UNITED STATES; YOUNG ADULT;

EID: 84881361043     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2013.787629     Document Type: Article

References (44)

1. Brownell 1. B, Oppenheimer DR, Hughes JT. The central nervous system in motor neuron disease. J Neurol Neurosurg Psychiatry. 1970 ; 33: 338-57
2. National Institute for Health and Clinical Excellence. Riluzole (Rilutek) for the treatment of Motor Neurone Disease. Technology appraisal TA20. London: NICE; January 2001
3. Rowland LP. D iagnosis of amyotrophic lateral sclerosis. J Neurol Sci. 1998 ; 160 (Suppl 1): S6-24
4. Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell JD, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: New evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008 ; 79: 6-11
5. Sorenson EJ, Stalker AP, Kurland L T, Windebank AJ. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925-1998. Neurology. 2002 ; 59: 280-2
6. Piemonte, Valle d'Aosta Register for Amyotrophic Lateral Sclerosis (PARALS). Incidence of ALS in Italy: Evidence for a uniform frequency in Western countries. Neurology. 2001 ; 56: 239-44
7. Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G. Incidence of ALS in Lombardy, Italy. Neurology. 2007 ; 68: 141-5
8. Sejvar 8. J J, Holman R C, Bresee J S, Kochanek K D, Schonberger LB. Amyotrophic lateral sclerosis mortality in the United States, 1979-2001. Neuroepidemiology. 2005 ; 25: 144-52
9. Marin B, Gil J, Preux P M, Funalot B, Couratier P. I ncidence of amyotrophic lateral sclerosis in the Limousin region of France, 1997-2007. Amyotroph Lateral Scler. 2009 ; 10: 216-20
10. Murphy M, Quinn S, Young J, Parkin P, Taylor B. I ncreasing incidence of ALS in Canterbury, New Zealand: A 22-year study. Neurology. 2008; 71: 1889-95
11. Fang F, Valdimarsdottir U, Bellocco R, Ronnevi L O, Sparen P, Fall K, et al. Amyotrophic lateral sclerosis in Sweden, 1991-2005. Arch Neurol. 2009 ; 66: 515-9
12. Chio A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R, et al. Epidemiology of ALS in Italy: A 10-year prospective population based study. Neurology. 2009 ; 72: 725-31
13. Gordon PH, Mehal JM, Holman RC, Rowland LP, Rowland AS, Cheek JE. Incidence of amyotrophic lateral sclerosis among American Indians and Alaska Natives. JAMA Neurol. 2013 ; 70:476-80
14. Alonso A, Logroscino G, Jick S S, Hernan M A. I ncidence and lifetime risk of motor neuron disease in the United Kingdom: A population based study. Eur J Neurol. 2009 ; 16: 745-51
15. Lilienfeld DE, Chan E, Ehland J, Godbold J, Landrigan PJ, Marsh G, et al. Rising mortality from motor neuron disease in the USA, 1962-84. Lancet. 1989 ; 1: 710-3
16. World Health Organization. International Statistical Classifi-cation of Diseases and Related Health Problems, Tenth Revision (ICD-10). Geneva: World Health Organization 1992
17. World Health Organization. M anual of the International Statistical Classifi cation of Diseases, Injuries, and Causes of Death, Based on Recommendations of the Ninth Revision Conference, 1975. Geneva: World Health Organization 1977
18. U.S. Department of Health and Human Services: Vital statistics mortality data, multiple cause detail, 1999-2009. Public use data tape contents and documentation package. Hyattsville, MD: Centers for Disease Control and Prevention, National Center for Health Statistics; 2012
19. U.S. Bureau of the Census. I ntercensal Estimates of the Population by Age, Sex, and Race: 2000-2009. Washington, DC: US Bureau of the Census 2012
20. U.S. Bureau of the Census. I ntercensal Estimates of the Population by Age, Sex, and Race: 1999. Washington, DC: US Bureau of the Census 2002
21. Klein RJ, Schoenborn CA. A ge adjustment using the 2000 projected U.S. population. Healthy People Statistical Notes, no. 20. National Center for Health Statistics, Hyattsville, MD; 2001
22. Kleinbaum DG, Kupper LL, Muller KE, Nizam A. A pplied Regression Analysis and Other Multivariable Methods. 3rd edn. Pacifi c Grove, CA: Duxbury Press; 1998
23. Lehmann E. N on-parametrics: Statistical Methods Based on Ranks. New York, NY: Wiley; 1975
24. Neilson S, Robinson I, Alperovitch A. R ising amyotrophic lateral sclerosis mortality in France 1968-1990: Increased life expectancy and inter-disease competition as an explanation. J Neurol. 1994 ; 241: 448-55
25. Govoni V, Granieri E, Capone J, Manconi M, Casetta I. I ncidence of amyotrophic lateral sclerosis in the local health district of Ferrara, Italy, 1964-1998. Neuroepidemiology. 2003 ; 22: 229-34
26. Beghi E, Logroscino G, Chio A, Hardiman O, Mitchell D, Swingler R, et al. The epidemiology of ALS and the role of population-based registries. Biochim Biophys Acta. 2006 ; 1762: 1150-7
27. Kurtzke J F, Beebe G W. E pidemiology of amyotrophic lateral sclerosis: 1. A case-control comparison based on ALS deaths. Neurology. 1980 ; 30: 453-62
28. Gordon PH, Artaud F, Aouba A, Laurent F, Meininger V, Elbaz A. Changing mortality for motor neuron disease in France (1968-2007): An age-period-cohort analysis. Eur J Epidemiol. 2011 ; 26: 729-37
29. Forbes RB, Colville S, Swingler RJ, Scottish A LSMNDR. The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 years or over. Age Ageing. 2004 ; 33: 131-4
30. Noonan CW, White MC, Thurman D, Wong LY. T emporal and geographic variation in United States motor neuron disease mortality, 1969-1998. Neurology. 2005 ; 64: 1215-21
31. Cronin S, Hardiman O, Traynor BJ. E thnic variation in the incidence of ALS: A systematic review. Neurology. 2007 ; 68: 1002-7
32. Zou Z Y, Wang X N, Liu M S, Sun Q, Li X G, Cui L Y, et al. Identifi cation of a novel missense mutation in angiogenin in a Chinese amyotrophic lateral sclerosis cohort. Amyotroph Lateral Scler. 2012 ; 13: 270-5
33. Benedet AL, Moraes CF, Camargos EF, Oliveira LF, Souza VC, Lins TC, et al. Amerindian genetic ancestry protects against Alzheimer's disease. Dement Geriatr Cogn Disord. 2012 ; 33: 311-7
34. Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: A population based mortality study. Neurology. 2009 ; 72: 1640-5
35. Alonso V, Villaverde-Hueso A, Hens M J, Morales-Piga A, Abaitua I, de la Paz MP. Increase in motor neuron disease mortality in Spain: Temporal and geographical analysis (1990-2005). Amyotroph Lateral Scler. 2011 ; 12: 192-8
36. Pradas J, Puig T, Rojas-Garcia R, Viguera ML, Gich I, Logroscino G. Amyotrophic lateral sclerosis in Catalonia: A population based study. Amyotroph Lateral Scler Frontotemporal Degener. 2013 ; Early Online: 16
37. Logroscino G, Beghi E, Zoccolella S, Palagano R, Fraddosio A, Simone IL, et al. Incidence of amyotrophic lateral sclerosis in southern Italy: A population based study. J Neurol Neurosurg Psychiatry. 2005 ; 76: 1094-8
38. Ragonese P, Cellura E, Aridon P, D 'Amelio M, Spataro R, Taiello AC, et al. Incidence of amyotrophic lateral sclerosis in Sicily: A population based study. Amyotroph Lateral Scler. 2012 ; 13: 284-7
39. Groman R, Ginsburg J, American College of Physicians Racial and ethnic disparities in health care: A position paper of the American College of Physicians. Ann Intern Med. 2004 ; 141: 226-32
40. Stickler DE, Royer JA, Hardin JW. A ccuracy and usefulness of ICD-10 death certifi cate coding for the identifi cation of patients with ALS: Results from the South Carolina ALS Surveillance Pilot Project. Amyotroph Lateral Scler. 2012 ; 13: 69-73
41. Chio A, Magnani C, Oddenino E, Tolardo G, Schiffer D. Accuracy of death certifi cate diagnosis of amyotrophic lateral sclerosis. J Epidemiol Community Health. 1992 ; 46: 517-8
42. Juergens SM, Kurland LT, Okazaki H, Mulder DW. A LS in Rochester, Minnesota, 1925-1977. Neurology. 1980 ; 30: 463-70
43. Yeo L, Lynch C, Hardiman O. V alidating population based registers for ALS: How accurate is death certifi cation? J Neurol. 2010 ; 257: 1235-9
44. Antao VC, Horton DK. The National Amyotrophic Lateral Sclerosis (ALS) Registry. J Environ Health. 2012 ; 75: 28-30